“BUY” This Mid Cap Pharma Stock With A Target Price of Rs. 870: Motilal Oswal

Motilal Oswal, a brokerage company, has set a buy recommendation on Eris Lifesciences' stock. The brokerage has set a target price of Rs. 870 for the stock and expects it to reach that level in a 12-month time frame from current

from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/3qrK63D
via IFTTT

Post a Comment

Please Select Embedded Mode To Show The Comment System.*

Previous Post Next Post